Bioactive Milk Peptides and Blood Pressure

Valio

Status and phase: Completed; Phase 3

Conditions: Stage 1 Hypertension

Treatments: Other: Placebo; Dietary Supplement: Milk peptides and plant sterols

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01031485

Valio-70

Details and patient eligibility

About

The purpose of this study is to investigate the effects of bioactive milk peptides on blood pressure in mildly hypertensive subjects.

Sex: All

Ages: 30 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age 30-60 years
• systolic blood pressure 140-160 mmHg and diastolic blood pressure 90-99 mmHg in office measurement
• apparently healthy

Exclusion criteria

• antihypertensive and lipid-lowering drugs
• unstable coronary artery disease, diabetes, malignant diseases, secondary hypertension
• BMI > 32 kg/m2
• milk allergy
• smoking
• alcohol abuse
• pregnancy, lactation
• simultaneous participation in other clinical trial

Trial design

0 participants in 2 patient groups, including a placebo group

Spread with milk peptides and plant sterols

Active Comparator group

Treatment:

Dietary Supplement: Milk peptides and plant sterols

Standard spread

Placebo Comparator group

Treatment:

Other: Placebo